Terms: = Lung cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
18 results:
1. CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.
Lou H; Wu Z; Wei G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186304
[TBL] [Abstract] [Full Text] [Related]
2. [Monitoring Blood Markers to Predict Nivolumab Effectiveness in Esophageal Carcinoma].
Funatsuya T; Tanaka Y; Honma M; Fukuoka H; Takahashi M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1139-1141. PubMed ID: 36281612
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of serum soluble interleukin-23 receptor and related T-helper 17 cell cytokines in non-small cell lung carcinoma.
Liu D; Xing S; Wang W; Huang X; Lin H; Chen Y; Lan K; Chen L; Luo F; Qin S; Liang R; Bai C; Xu J; Liu W
Cancer Sci; 2020 Apr; 111(4):1093-1102. PubMed ID: 32020720
[TBL] [Abstract] [Full Text] [Related]
5. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract] [Full Text] [Related]
6. Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells.
Yi H; Cho HJ; Cho SM; Jo K; Park JA; Kim NH; Amidon GL; Kim JS; Shin HC
Int J Oncol; 2012 Jul; 41(1):310-6. PubMed ID: 22552503
[TBL] [Abstract] [Full Text] [Related]
7. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract] [Full Text] [Related]
8. [A case of intravascular lymphomatosis with no abnormal findings on chest computed tomography and with diffuse pulmonary uptake of 67Ga on scintigraphy].
Iwagami Y; Sumitani M; Imahashi Y; Kiyota H; Kawano Y; Takifuji N; Takeda K; Kashii T
Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):923-7. PubMed ID: 17233388
[TBL] [Abstract] [Full Text] [Related]
9. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
10. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of serum levels of cytokines and intercellular adhesion molecule-1 (ICAM-1) in astrocytic tumours.
Nano R; Capelli E; Argentina F; Facoetti A; Gerzeli G
Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):525-8. PubMed ID: 12899444
[TBL] [Abstract] [Full Text] [Related]
12. [Intravascular large B cell lymphoma with migratory local high density shadow by chest CT and diagnosed by transbronchial lung biopsy].
Okawa Y; Usui N; Uno S; Dobashi N; Kasama K; Kobayashi M
Rinsho Ketsueki; 2002 Jul; 43(7):567-72. PubMed ID: 12229127
[TBL] [Abstract] [Full Text] [Related]
13. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
Vuoristo MS; Laine S; Huhtala H; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Kellokumpu-Lehtinen P
Eur J Cancer; 2001 Sep; 37(13):1629-34. PubMed ID: 11527688
[TBL] [Abstract] [Full Text] [Related]
14. Effects on host of modified PVP therapy combined with biological response modifiers in lung cancer.
Katoh R; Takenoshita S; Shimizu Y; Tanaka S; Yajima Y; Nagamachi Y
Oncol Rep; 1998; 5(1):103-7. PubMed ID: 9458302
[TBL] [Abstract] [Full Text] [Related]
15. [Preliminary study on change of interleukin-2 and its receptor in the elderly].
Dong B; Zhou J; Wang Z
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):342-4. PubMed ID: 8586407
[TBL] [Abstract] [Full Text] [Related]
16. Soluble interleukin-2 receptors (sil-2R) and neuron specific enolase (NSE) in small cell lung carcinoma.
Sarandakou A; Poulakis N; Rizos D; Trakakis E; Phocas I
Anticancer Res; 1993; 13(1):173-5. PubMed ID: 8386493
[TBL] [Abstract] [Full Text] [Related]
17. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
[TBL] [Abstract] [Full Text] [Related]
18. Soluble interleukin-2 receptors and other markers in primary lung cancer.
Poulakis N; Sarandakou A; Rizos D; Phocas I; Kontozoglou T; Polyzogopoulos D
Cancer; 1991 Sep; 68(5):1045-9. PubMed ID: 1717123
[TBL] [Abstract] [Full Text] [Related]
